Safety and outcome of hepatitis B core antibody-positive donors in right-lobe living donor liver transplantation

Liver Transplantation

Volumn 9, Issue 8, 2003, Pages 827-832

  Lo, Chung Mau ^a   Fan, Sheung Tat ^a   Liu, Chi Leung ^a   Yong, Boon Hun ^a   Wong, Yik ^a   Ng, Irene Oi Lin ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B CORE ANTIBODY; PROTHROMBIN;

ADULT; ANTIBODY DETECTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD LEVEL; CHOLESTASIS; CONTROLLED STUDY; DEMOGRAPHY; FATTY LIVER; FEMALE; FOLLOW UP; HEPATITIS B; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFECTION RISK; LIVER FIBROSIS; LIVER FUNCTION; LIVER LOBECTOMY; LIVER SIZE; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; SAFETY; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT CONTRAINDICATION; VIRUS TRANSMISSION;

EID: 0041989678     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50115     Document Type: Article

References (20)

1. Brechot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-276.
2. Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation 1995; 59:230-234.
3. Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997;113:1668-1674.
4. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997;64:1582-1584.
5. Prieto M, Gomez MD, Berenguer M, Cordoba J, Rayon JM, Pastor M, et al. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl 2001;7:51-58.
6. Lee KH, Wai CT, Lim SG, Manjit K, Lee HL, Da Costa M, et al. Risk for de novo hepatitis B from antibody to hepatitis B core antigen-positive donors in liver transplantation in Singapore. Liver Transpl 2001;7:469-270.
7. Dodson SF, Bonham CA, Geller DA, Cacciarelli TV, Rakela J, Fung JJ. Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors. Transplantation 1999;68:1058-1061.
8. Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, et al. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBc positive donors. Gut 2002;50:95-99.
9. Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, et al. Transmission of hepatitis B infection from hepatitis B core antibody-positive liver allografts is prevented by lamivudine therapy. Liver Transpl 2001;7:513-517.
10. Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-499.
11. Marcos A, Fisher RA, Ham JM, Olzinski AT, Shiffman ML, Sanyal AJ, et al. Selection and outcome of living donors for adult to adult right lobe transplantation. Transplantation 2000;69: 2410-2415.
12. Lok AS, Lai CL, Wu PC, Wong VC, Yeoh EK, Lin HJ. Hepatitis B virus infection in Chinese families in Hong Kong. Am J Epidemiol 1987;126:492-499.
13. Lo CM, Fan ST, Liu CL, Wei WI, Lo RJ, Lai CL, et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997;226:261-270.
14. Fan ST, Lo CM, Liu CL, Yong BH, Chan JK, Ng IO. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000;135:336-340.
15. Sakamoto S, Uemoto S, Uryuhara K, Kim ID, Kiuchi T, Egawa H, et al. Graft size assessment and analysis of donors for living donor liver transplantation using right lobe. Transplantation 2001;71:1407-1413.
16. Department of health: Public Health Report No-3 Viral Hepatitis and Liver Cancer and Unintentional Injuries in Children. Hong Kong: Department of Health, 1998.
17. Marcos A, Fisher RA, Ham JM, Shiffman ML, Sanyal AJ, Luketic VA, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379.
18. Okada S, Sato T, Okusaka T, Ishii H, Ikeda M, Nakasuka H, et al. Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease. Br J Cancer 1998;77:2028-2031.
19. Maynard JE. Hepatitis B: Global importance and need for control. Vaccine 1990;8(suppl):S18-S20.
20. Lo CM, Cheung ST, Lai CL, Liu CL, Ng IOL, Yuen MF, et al. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg 2001;233:276-281.